Cargando…
NARASIMHA: Novel Assay based on Targeted RNA Sequencing to Identify ChiMeric Gene Fusions in Hematological Malignancies
Autores principales: | Patkar, Nikhil, Bhanshe, Prasanna, Rajpal, Sweta, Joshi, Swapnali, Chaudhary, Shruti, Chatterjee, Gaurav, Tembhare, Prashant, Dhamne, Chetan, Prasad, Maya, Moulik, Nirmalya Roy, Shetty, Dhanalaxmi, Gokarn, Anant, Bonda, Avinash, Nayak, Lingaraj, Punatkar, Sachin, Bagal, Bhausaheb, Sengar, Manju, Narula, Gaurav, Khattry, Navin, Banavali, Shripad, Subramanian, P. G., Gujral, Sumeet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7200652/ https://www.ncbi.nlm.nih.gov/pubmed/32372024 http://dx.doi.org/10.1038/s41408-020-0313-6 |
Ejemplares similares
-
Machine learning derived genomics driven prognostication for acute myeloid leukemia with RUNX1-RUNX1T1
por: Shaikh, Anam Fatima, et al.
Publicado: (2020) -
A novel machine-learning-derived genetic score correlates with measurable residual disease and is highly predictive of outcome in acute myeloid leukemia with mutated NPM1
por: Patkar, Nikhil, et al.
Publicado: (2019) -
Utility of Immunophenotypic Measurable Residual Disease in Adult Acute Myeloid Leukemia—Real-World Context
por: Patkar, Nikhil, et al.
Publicado: (2019) -
P454: ACUTE MYELOID LEUKEMIA (AML) WITH IDH1 AND IDH2 MUTATIONS CAN BE EFFECTIVELY RISK STRATIFIED BASED ON THE PRESENCE ADVERSE RISK GENOMIC FEATURES.
por: Bhide, Aniket, et al.
Publicado: (2023) -
Clinical impact of measurable residual disease monitoring by ultradeep next generation sequencing in NPM1 mutated acute myeloid leukemia
por: Patkar, Nikhil, et al.
Publicado: (2018)